Neglected zoonoses and antimicrobial resistance : impact on one health and sustainable development goals /
Neglected Zoonoses and Antimicrobial Resistance: Impact on One Health and Sustainable Development Goals provides a thorough examination of how neglected zoonoses and antimicrobial resistance together hinder the achievement of sustainable development goals declared by the United Nations in the pursui...
Gorde:
| Beste egile batzuk: | , , |
|---|---|
| Formatua: | Baliabide elektronikoa eBook |
| Hizkuntza: | ingelesa |
| Argitaratua: |
London ; San Diego, CA:
Academic Press, an imprint of Elsevier,
[2025]
|
| Gaiak: | |
| Sarrera elektronikoa: | ScienceDirect |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|
MARC
| LEADER | 00000cam a22000007i 4500 | ||
|---|---|---|---|
| 001 | on1472851945 | ||
| 003 | OCoLC | ||
| 005 | 20260915095209.0 | ||
| 006 | m o d | ||
| 007 | cr cnu---unuuu | ||
| 008 | 241201s2025 enkab ob 001 0 eng d | ||
| 040 | |a YDX |b eng |e rda |c YDX |d OPELS |d OCLCO |d OCLCQ |d YDX |d N$T |d OCLCL |d SFB |d OCLCF |d OCLCO |d OCLCQ | ||
| 020 | |a 0443160635 |q electronic book | ||
| 020 | |a 9780443160639 |q (electronic bk.) | ||
| 020 | |z 9780443160622 |q paperback | ||
| 020 | |z 0443160627 |q paperback | ||
| 035 | |a (OCoLC)1472851945 | ||
| 050 | 4 | |a RA639 |b .N44 2025 | |
| 082 | 0 | 4 | |a 614.5/6 |2 23/eng/20241202 |1 https://id.oclc.org/worldcat/ddc/E47v6WwMq6ttFKVj39RkMdRhjd |
| 245 | 0 | 0 | |a Neglected zoonoses and antimicrobial resistance : |b impact on one health and sustainable development goals / |c edited by Indranil Samanta, Samiran Bandyopadhyay, Olivier Sparagano. |
| 264 | 1 | |a London ; |a San Diego, CA: |b Academic Press, an imprint of Elsevier, |c [2025] | |
| 300 | |a 1 online resource : |b illustrations (chiefly color), maps (chiefly color) | ||
| 336 | |a text |b txt |2 rdacontent | ||
| 337 | |a computer |b c |2 rdamedia | ||
| 338 | |a online resource |b cr |2 rdacarrier | ||
| 340 | |p illustration |0 http://rdaregistry.info/termList/IllusContent/1014 |2 rdaill | ||
| 340 | |g polychrome |0 http://rdaregistry.info/termList/RDAColourContent/1003 |2 rdacc | ||
| 340 | |p map |0 http://rdaregistry.info/termList/IllusContent/1008 |2 rdaill | ||
| 504 | |a Includes bibliographical references and index. | ||
| 588 | |a Description based on online resource; title from digital title page (viewed on April 24, 2025). | ||
| 505 | 0 | |a Front Cover -- NEGLECTED ZOONOSES AND ANTIMICROBIAL RESISTANCE -- NEGLECTED ZOONOSES AND ANTIMICROBIAL RESISTANCE: IMPACT ON ONE HEALTH AND SUSTAINABLE DEVELOPMENT GOALS -- Copyright -- Dedication -- Contents -- Contributors -- About the editors -- Preface -- 1 -- Sustainable Development Goal -- 1. Sustainable Development Goals -- 2. Origin of SDG: Transition from MDG -- References -- 2 -- Neglected zoonotic diseases -- 1. Introduction -- 1.1 Understanding neglected zoonotic diseases -- 1.2 Impact and consequences -- 2. Conclusion -- References -- 3 -- Neglected cystic and alveolar echinococcosis -- 1. Public health relevance, risk factors, taxonomy, and genetic variation -- 1.1 Public health relevance -- 1.2 Risk factors -- 1.3 Taxonomy and genetic variation -- 2. Biology and ecology of E. multilocularis and E. granulosus s.l. -- 2.1 Life cycles of Echinococcus granulosus sensu lato complex -- 2.2 Life cycle of Echinococcus multilocularis -- 2.3 Infectivity, pathogenicity, and parasite-host interactions -- 3. Epidemiology of cystic and alveolar echinococcosis -- 3.1 Global distribution of cystic echinococcosis -- 3.2 Global distribution of alveolar echinococcosis -- 4. Surveillance and control of cystic and alveolar echinococcosis -- 4.1 Surveillance and control of cystic echinococcosis -- 4.1.1 Targeted control programme for CE -- 4.1.2 Focus on the control options for E. granulosus s.l. -- 4.1.3 Focus on the surveillance options for E. granulosus s.l. -- 4.1.4 Assumptions and ultimate goals for a successful CE control programme -- 4.2 Surveillance and control options for alveolar echinococcosis -- 4.2.1 Surveillance of E. multilocularis in foxes -- 4.2.2 Control of E. multilocularis in foxes -- 5. Diagnosis and clinical management of cystic and alveolar echinococcosis? -- 5.1 Clinical features of human cystic and alveolar echinococcosis. | |
| 505 | 8 | |a 5.2 Diagnosis of cystic and alveolar echinococcosis -- 5.2.1 Laboratory diagnosis -- 5.3 Clinical management of cystic and alveolar echinococcosis -- References -- 4 -- Cysticercosis: Matter of concern -- 1. Mode of transmission -- 2. Disease process -- 3. Changeover of the traditional clinical symptoms into the current one/epidemiology -- 4. Modern diagnostic techniques -- 5. Treatment protocol -- 6. Antiparasitic resistance -- 7. Prevention and control strategy -- 8. Vaccines used recently or under development -- 9. Conclusion -- References -- 5 -- Zoonotic sleeping sickness (Trypanosoma brucei) -- 1. Introduction -- 2. Morphology and life cycle of Trypanosoma brucei -- 3. Circadian disruption by sleeping sickness infection -- 4. Infection and disease course -- 5. Epidemiology, transmission, and risk factors -- 6. Diagnosis -- 7. Treatment and management -- 8. In gambiense-HAT -- 9. In rhodesiense-HAT -- 10. Elimination strategies -- 11. Vector control strategy -- 12. Conclusion -- References -- 6 -- Leishmaniasis -- 1. Introduction -- 2. Etiology -- 3. Distribution -- 4. Host species and reservoirs -- 5. Transmission and life cycle -- 6. Pathogenesis -- 7. Clinical features -- 8. Diagnosis -- 9. Treatment -- 9.1 Pentavalent antimonials -- 9.2 Amphotericin B -- 9.3 Pentamidine -- 9.4 Paromomycin -- 9.5 Miltefosine -- 9.6 Sitamaquine -- 9.7 Immunotherapy -- 10. Prevention and control -- 10.1 Personal protection -- 10.2 Chemical control -- 10.3 Environmental modification -- 10.4 Reservoir control -- 10.5 Health education -- 10.6 Vaccines -- References -- 7 -- Zoonotic tuberculosis -- 1. Introduction -- 2. Mycobacteria -- 3. The importance of zoonotic tuberculosis -- 4. Pathogenesis, clinical presentation, and pathology -- 5. Diagnostic techniques -- 6. Strategies of TB control and treatment -- 7. Vaccines -- 8. Conclusion remarks -- References. | |
| 505 | 8 | |a 8 -- Anthrax -- 1. Epidemiological distribution -- 2. Etiology -- 3. Hosts -- 4. Mode of transmission -- 5. Disease process -- 6. Changeover of the traditional clinical symptoms into the current one -- 7. Economic importance -- 8. Modern diagnostic techniques -- 9. Treatment protocol -- 10. Antibacterial resistance -- 11. Prevention and control strategies -- 12. Vaccines used recently or under development -- 13. Conclusion -- Acknowledgments -- References -- Further reading -- 9 -- Brucellosis: A neglected zoonosis -- 1. Introduction -- 2. Etiology -- 3. Brucella genome -- 4. Distribution and population at risk -- 5. Socioeconomic impact -- 6. Hosts and mode of transmission -- 7. Risk factors associated with transmission -- 8. Diagnosis -- 9. Control measures -- 10. Conclusion -- References -- 10 -- Leptospirosis -- 1. Introduction -- 2. Etiology -- 3. Host range -- 4. Mode of transmission -- 5. Disease process -- 5.1 Leptospiral antigens and their role -- 5.2 Adhesion to the cells and entry -- 5.3 Virulence factors and the host's immune system's evasion -- 5.4 Disease development -- 6. Changeover of the traditional clinical symptoms into the current one -- 6.1 In humans -- 6.2 In animals -- 6.2.1 Cattle -- 6.2.2 Buffalo -- 6.2.3 Sheep -- 6.2.4 Goat -- 6.2.5 Swine -- 6.2.6 Horses and other pack animals -- 6.2.7 Dog -- 6.2.8 Cat -- 7. Economic importance -- 8. Treatment protocol -- 8.1 In humans -- 8.2 In animals -- 9. Antibacterial resistance -- 10. Prevention and control strategy -- 11. Vaccines used recently or under development -- 11.1 Bacterins -- 11.2 Attenuated vaccines -- 11.3 LPS-depleted vaccines -- 11.4 Recombinant protein vaccines -- 11.5 Recombinant subunit vaccine -- 11.6 DNA vaccines -- 12. Conclusion -- References -- 11 -- Relapsing fever borreliosis -- 1. Introduction -- 2. History -- 3. Distribution -- 3.1 Africa -- 3.2 Asia and Eurasia. | |
| 505 | 8 | |a 3.3 Europe -- 3.4 The Americas -- 4. Epidemiology -- 4.1 Louse-borne relapsing fever -- 4.2 Tick-borne relapsing fever -- 5. Etiology -- 6. Hosts -- 6.1 Rodents -- 6.2 Avians -- 6.3 Bats -- 6.4 Livestock and other animals -- 7. Mode of transmission -- 8. Disease process -- 8.1 Vector-Borrelia interactions -- 8.2 Host interactions -- 9. Changeover of the clinical symptoms -- 10. Economic importance -- 11. Classical and modern diagnostic techniques -- 11.1 Microscopical examination -- 11.2 Serological methods -- 11.3 In vitro cultivation -- 11.4 Polymerase chain reaction -- 11.5 LTT, MELISA, and ELISpot tests -- 11.6 Luminex-based, Immuno-PCR techniques -- 12. Treatment protocol and antibacterial resistance -- 12.1 Louse-borne relapsing fever -- 12.2 Tick-borne relapsing fever -- 12.3 Additional considerations -- 13. Prevention and control strategies -- 13.1 Louse-borne RF -- 13.2 Tick-borne RF -- 14. Vaccines -- References -- 12 -- Rickettsioses -- 1. Introduction -- 2. Distribution and epidemiology -- 3. Etiology -- 4. Hosts -- 5. Mode of transmission -- 6. Pathogenesis -- 7. Clinical manifestations -- 7.1 Rickettsioses syndrome with a low probability of inoculation eschar -- 7.2 Rickettsioses syndrome with a probability of inoculation eschar -- 8. Economic importance -- 9. Diagnosis -- 10. Treatment -- 10.1 Antibacterial resistance -- 11. Prevention and control -- 11.1 Vaccines used recently or under development -- References -- 13 -- Rabies -- 1. Introduction -- 2. Etiology -- 3. Host -- 4. Modes of transmission -- 5. Disease process -- 6. Incubation period -- 7. Epidemiology -- 8. Clinical manifestation of rabies -- 9. Changeover of traditional clinical symptoms into current ones -- 10. Economic importance of rabies -- 11. Diagnosis -- 12. Prevention and control strategy -- 12.1 Prevention and control in animals. | |
| 505 | 8 | |a 12.2 Prevention and control in humans -- 13. Treatment protocol -- 14. Vaccines used recently or under development -- 14.1 Vaccines for use in domestic animals -- 14.2 Vaccines for use in wild animals -- 14.3 Vaccines for use in humans -- 15. How rabies control is related to sustainable development goals? -- 16. Some neglected but significant issues in rabies control -- 16.1 Rabies in wildlife and its possible role in spillover to domestic animals and humans -- 16.2 Role of waste management on stray dog population management and rabies control -- 16.3 Influence of socioeconomic factors in the control of rabies -- 16.4 Role of epidemiological modeling techniques in rabies prevention and control -- 16.5 Lack of inclusion of PrEP in human immunization programs -- 17. Conclusions -- Acknowledgments -- References -- 14 -- Zoonotic antimicrobial resistance: Impact on human and animal health -- 1. Definition -- 2. Characteristics -- 3. Correlation with neglected zoonotic diseases -- 4. Impact on animal health -- 5. Impact on human health -- References -- Further reading -- 15 -- Dual obstacles to sustainable development goals -- 1. How NZDs affect SDGs? -- 2. What an antimicrobial resistance affects SDG? -- References -- 16 -- Mitigation strategy for neglected zoonotic diseases and antimicrobial resistance -- 1. Introduction -- 2. Mitigation strategies -- 2.1 Food-borne-related NZDs -- 2.2 Human and anthropogenic factors -- 2.3 Environmental factors -- 3. Antimicrobial resistance -- 4. Conclusion -- References -- Index -- Back Cover. | |
| 520 | |a Neglected Zoonoses and Antimicrobial Resistance: Impact on One Health and Sustainable Development Goals provides a thorough examination of how neglected zoonoses and antimicrobial resistance together hinder the achievement of sustainable development goals declared by the United Nations in the pursuit of a disease-free world. | ||
| 650 | 0 | |a Zoonoses. | |
| 650 | 2 | |a Zoonoses |0 (DNLM)D015047 | |
| 650 | 6 | |a Zoonoses. |0 (CaQQLa)201-0001356 | |
| 650 | 7 | |a Zoonoses |2 fast |0 (OCoLC)fst01184758 | |
| 655 | 4 | |a Electronic books. | |
| 700 | 1 | |a Samanta, Indranil, |e editor. |1 https://id.oclc.org/worldcat/entity/E39PCjFP6xrHQXXFYyTQ44yRPP | |
| 700 | 1 | |a Bandyopadhyay, Samiran, |e editor. |1 https://id.oclc.org/worldcat/entity/E39PCjFDDjhJrJDJdM8ktjmVBX | |
| 700 | 1 | |a Sparagano, Olivier A. E., |e editor. |1 https://id.oclc.org/worldcat/entity/E39PBJhCDHPqYCmRH9Qx3jRMyd | |
| 776 | 0 | 8 | |i Print version: |z 0443160627 |z 9780443160622 |w (OCoLC)1406406851 |
| 856 | 4 | 0 | |3 ScienceDirect |u https://www.sciencedirect.com/science/book/9780443160622 |